Sun, Feb 1, 2015, 12:46 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • dinepat203 dinepat203 Feb 1, 2013 9:19 AM Flag

    BLOCKED GLAXO / EVERYONE ON USE OF PURE EPA...AMARIN ON TRACK FOR NCE

    Amarin's U.S. Patent Application Serial Number 13/272,520 titled "Compositions and Methods for Lowering Triglycerides." This application includes claims intended to protect the proposed Vascepa® (icosapent ethyl) indication based on Amarin's Phase 3 ANCHOR clinical trial results.

    The claims in this allowed application cover a method of use relating to Vascepa's ANCHOR indication. Specifically, the allowed independent claims covers use of about 4 grams per day of highly pure icosapent ethyl, or EPA, including Vascepa, to lower triglycerides and LDL-C.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 2500 tons per year or 2.27 million Kg / 5,000,000 lbs (2500 tons from BASF web site)

      2,270,000,000 grams divided by 4 gram dose = 567,500,000 4 gram doses per year

      Enough to supply 1,554,794 pts per year with 4 grams.

      Anchor indication is about 44,000,000 patients

      3.5% penetration of Anchor's 44,000,000

      3.9% penetration of Marine indication

      $6 per day for a 4 gram dose = $3.4 Billion
      ----------------
      Amarin will still need more API.

      $50+ stock folks...

      Sentiment: Strong Buy

 
AMRN
1.02-0.01(-0.97%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.